Skip to content

Depression: all studies

Page 48 of 1,034: studies 471 to 480 of 10,336, newest first. Back to the depression overview

Research

Psychedelic therapy and postpartum depression: priorities and prospects

Therapeutic Advances in Psychopharmacology March 1, 2026 Guillaume Thuery, Frank Crossen, Daniel Mc Loone et al. 1 citation

Approximately 15% of pregnant women experience postpartum depression (PPD). Even with currently available antidepressant treatments, many women will continue to be impaired by symptoms. Psychedelic therapy offers a promising transdiagnostic therapeutic strategy for several mental health disorders, and early results from current trials suggest that serotonergic psychedelics may represent a...

DOI: 10.1177/20451253251408280 (opens in new tab) Postpartum period Medline Pregnancy Psychotherapist +2

Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression

Value in Health Regional Issues March 1, 2026 Yosr Ziadi, Taehwan Park 1 citation

BACKGROUND: Treatment-resistant depression (TRD) imposes a substantial public health and economic burden. Although psilocybin-assisted therapy (PAT) has shown clinical promise, its economic value remains uncertain. This study evaluated the cost-effectiveness of PAT compared with the standard of care for TRD. METHODS: A Markov model adopting a US healthcare perspective simulated patient...

A Mixed Methods Study on the Effects of a Compassion Meditation Program on Ego Integrity and Depression among Older Adults

Korean Journal of Social Welfare February 28, 2026 Sun Young Yun

본 연구는 서구의 마음챙김 자기연민(MSC) 프로그램을 한국 노인의 인지•정서적 특성에 부합하도록 ‘감각 회상 통합’ 구조로 재구성한 연민명상 프로그램의 효과를 검증하였다. 수도권에 거주하는 노인 10명을 대상으로 12회기 집단 프로그램을 실시하고, 혼합연구방법을 적용하였다. 양적 자료는 윌콕슨 부호순위 검정을 통해 분석하였으며, 질적 자료는 주제 분석법을 활용하였다. 연구 결과, 신체 감각 중심 개입은 노인의 신체적 안전기지를 형성하여 자기친절을 촉진하였고, 인생 곡선을 활용한 회상은 고립감을 유의하게 감소시키며(p = .024) 고통의 보편성 인식을 통해 자아통합을 촉진하는 과정으로 나타났다. 또한 실존적 마음챙김은 우울 수준을 유의하게 감소시키며(p = .049), 죽음 수용을 매개로 삶의...

DOI: 10.20970/kasw.2026.78.1.011 (opens in new tab) Meditation Depression economics Self-compassion Clinical psychology +1

Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making

Instituto Politécnico do Porto February 27, 2026 C Faria, Diana Dias Da Silva, João José Sousa

Background: Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric condition associated with substantial clinical, social, and economic burden [1,2]. Despite the availability of conventional antidepressants, their limited effectiveness, delayed onset of action, and high relapse rates have renewed interest in innovative therapeutic approaches [3,4,5]. Psilocybin-assisted...

The Effects of Mindfulness Techniques on Anxiety, Depression, and Stress, with an Emphasis on Gratitude: A Systematic Review and Meta-Analysis

Healthcare February 27, 2026 Mădălina Sarca, Adriana Cojocaru, Raluca Dumache et al.

Background/Objectives: Mental health conditions such as anxiety, depression, and stress remain among the leading global causes of disability. Mindfulness-Based Interventions (MBIs) have gained increasing attention as effective non-pharmacological strategies for reducing psychological distress. Methods: This systematic review examined 30 randomized controlled trials and quasi-experimental...

DOI: 10.3390/healthcare14050601 (opens in new tab) Mindfulness Anxiety Psychological intervention Mental health +10

Ketamine pharmacotherapy for major depressive disorder: A narrative review

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 27, 2026 Chris H. Miller, Angela Hickman, Caitlin Baten et al. 2 citations

Ketamine pharmacotherapy provides a novel treatment option for major depressive disorder (MDD) and has generated a large, growing body of research regarding its biochemical and clinical properties. This narrative review summarizes the history of ketamine's development, beginning as a general anesthetic, continuing with a discovery of its antidepressant properties, and leading up to its landmark...

A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine) in patients with treatment-resistant depression

Journal of Psychopharmacology February 27, 2026 Claire T. Roberts, Mathieu Seynaeve, Anna O. Ermakova et al.

Results confirmed the safety profile of BPL-003 in a TRD population. A rapid and sustained reduction in MADRS score was observed over 12 weeks, suggesting BPL-003 could be beneficial in TRD, warranting investigation in larger controlled trials.

Traditional Buddhist Mindfulness versus Secular Mindfulness-based Cognitive Therapy for Residual Depressive Symptoms in Patients Treated for Depressive Disorder: A Pilot Randomized Controlled Trial

Research Square February 26, 2026 Anuradha Baminiwatta, Takeshi Hamamura, Anjalika Madhubhashini et al. preprint

Abstract Objectives To compare the efficacy, acceptability, and feasibility of traditional Buddhist mindfulness (TBM) versus secular mindfulness-based cognitive therapy (MBCT) for residual depressive symptoms, and to examine whether TBM is non-inferior to MBCT in improving depressive symptoms and psychological wellbeing. Methods In this pilot randomized controlled trial, Buddhist adults with...

Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review

International Journal of Molecular Sciences February 26, 2026 James Chmiel, Filip Rybakowski

Psychedelic-assisted therapies (PATs) can produce rapid and sustained antidepressant effects, yet variability in response remains substantial. Identifying predictors and moderators is essential for optimising patient selection, preparation, and delivery. To map and synthesise the evidence on the predictors of antidepressant response to classic/serotonergic psychedelics administered with...

DOI: 10.3390/ijms27052202 (opens in new tab) Comorbidity Antidepressant Psycinfo Medline +5